Article Data

  • Views 177
  • Dowloads 138

This is a correction to: European Journal of Gynaecological Oncology. 2025; 46(11): 60-69. https://doi.org/10.22514/ejgo.2025.138

Corrections

Open Access

Correction: FKBP10 ablation promotes breast cancer chemosensitivity via targeting autophagy and the AKT/CREB axis

  • Long Cheng1
  • Xiang Zhu1
  • Zihe Xing1
  • Xiaoning Li1
  • Wuqin Xu2,*,

1Clinical Laboratory, The First Affiliated Hospital of Wannan Medical College, 241001 Wuhu, Anhui, China

2Department of Pathology, The First Affiliated Hospital of Wannan Medical College, 241001 Wuhu, Anhui, China

DOI: 10.22514/ejgo.2026.064 Vol.47,Issue 3,October 2026 pp.168-168

Published: 15 October 2026

*Corresponding Author(s): Wuqin Xu E-mail: xuwuqin06@126.com

PDF (221.18 kB) View Full-text

Cite and Share

Long Cheng, Xiang Zhu, Zihe Xing, Xiaoning Li, Wuqin Xu. Correction: FKBP10 ablation promotes breast cancer chemosensitivity via targeting autophagy and the AKT/CREB axis. European Journal of Gynaecological Oncology. 2026; 47(3): 168-168. doi: 10.22514/ejgo.2026.064

References

[1] Cheng L, Zhu X, Xing ZH, Li XN, Xu WQ. FKBP10 ablation promotes breast cancer chemosensitivity via targeting autophagy and the AKT/CREB axis. European Journal of Gynaecological Oncology. 2025; 46: 60–69.

Submission Turnaround Time

Top